Bonk (NASDAQ:BNKK – Get Free Report) and Loomis (OTCMKTS:LOIMF – Get Free Report) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.
Profitability
This table compares Bonk and Loomis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Bonk | -952.21% | -137.47% | -122.67% |
| Loomis | 6.06% | 15.08% | 4.90% |
Earnings and Valuation
This table compares Bonk and Loomis”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Bonk | $2.12 million | 5.36 | -$68.19 million | ($3.82) | -0.37 |
| Loomis | $3.11 billion | 1.02 | $161.68 million | $2.96 | 16.05 |
Loomis has higher revenue and earnings than Bonk. Bonk is trading at a lower price-to-earnings ratio than Loomis, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Bonk has a beta of 1.91, suggesting that its stock price is 91% more volatile than the S&P 500. Comparatively, Loomis has a beta of -0.86, suggesting that its stock price is 186% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current ratings and target prices for Bonk and Loomis, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Bonk | 1 | 0 | 0 | 0 | 1.00 |
| Loomis | 0 | 1 | 0 | 0 | 2.00 |
Insider & Institutional Ownership
12.6% of Bonk shares are owned by institutional investors. 51.6% of Bonk shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Summary
Loomis beats Bonk on 8 of the 12 factors compared between the two stocks.
About Bonk
Safety Shot, Inc., a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. The company was incorporated in 2018 and is headquartered in Jupiter, Florida.
About Loomis
Loomis AB (publ) provides solutions for the distribution, payments, handling, storage, and recycling of cash and other valuables. The company offers a range of solutions for cash in transit, cash management services, foreign exchange services, automated teller machines, automated solutions, and international valuables logistics, as well as operates Loomis Pay, a payment service that enables processing of various types of payment methods, such as card, cash, and digital alternatives. It serves financial institutions, banks, retailers, commercial enterprises, and other customers, as well as public sector in Sweden, the United States, France, Switzerland, Spain, the United Kingdom, and internationally. Loomis AB (publ) was founded in 1852 and is headquartered in Stockholm, Sweden.
Receive News & Ratings for Bonk Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bonk and related companies with MarketBeat.com's FREE daily email newsletter.
